Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

Journal of Experimental Medicine

Volumn 196, Issue 3, 2002, Pages 389-399

  Hoffmann, Petra ^a   Ermann, Joerg ^a   Edinger, Matthias ^a   Garrison Fathman, C ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunity; IL 10; Immune regulation; Mixed leukocyte reaction; T lymphocytes

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CLINICAL EXAMINATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD4; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037025943     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020399     Document Type: Article

References (50)

1. GVHD: Overview on pathophysiology, incidence, clinical and biological features
2. Graft-versus-host disease: Pathophysiological and clinical aspects
3. Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction
4. Pathophysiologic mechanisms of acute graft-vs.-host disease
5. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation
6. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
7. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
8. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences
9. In vitro comparison of two methods of T cell depletion associated with different rates of graft failure after allogeneic marrow transplantation
10. Prevention of graft-versus-host disease by ex vivo T cell depletion: Reduction in graft failure with augmented total body irradiation
11. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT
12. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β
13. CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses
14. - subpopulations
15. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
16. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro
17. + immunoregulatory T cells that control autoimmune diabetes
18. Animal models of autoimmunity and their relevance to human diseases
19. Control of intestinal inflammation by regulatory T cells
20. + suppressor T cells
21. Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment
22. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
23. + immunoregulatory cells
24. CD4(+)CD25(+) T cells facilitate the induction of T cell anergy
25. CD4(+) regulatory T cells
26. + regulatory T cells is mediated by cell surface-bound transforming growth factor β
27. - T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
28. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
29. Human CD4(+)CD25(+) cells: A naturally occurring population of regulatory T cells
30. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
31. CD25(+)CD4(+) regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses
32. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells
33. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
34. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
35. + regulatory cells that control intestinal inflammation
36. + T cells with regulatory properties isolated from peripheral blood
37. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade
38. + T cells reciprocally regulate acute graft versus host disease
39. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: Impact on allogeneic bone marrow transplantation
40. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10
41. + T cells with regulatory properties from human blood
42. Human anergic/suppressive CD4(+)CD25(+) T cells: A highly differentiated and apoptosis-prone population
43. + cells regulate CD8 cell anergy in neonatal tolerant mice
44. + suppressor T cells in vivo
45. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-αβ
46. Pre-B cells in mouse bone marrow: Immunofluorescence stathmokinetic studies of the proliferation of cytoplasmic mu-chain-bearing cells in normal mice
47. T regulatory cells 1 inhibit a Th2-specific response in vivo
48. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
49. Infectious tolerance
50. + immunoregulatory T cells is antigen nonspecific